Preemptive intravenous iron therapy versus autologous whole blood therapy for early postoperative hemoglobin level in patients undergoing bimaxillary orthognathic surgery: a prospective randomized noninferiority trial.
Min Suk ChaeMihyun LeeMin Ho ChoiJe Uk ParkMisun ParkYoung Hoon KimHoon ChoiJin JooYoung-Eun MoonPublished in: BMC oral health (2021)
Clinical Research Information Service, Republic of Korea, approval number: KCT0003680 on March 27, 2019. https://cris.nih.go.kr/cris/search/search_result_st01_kren.jsp?seq=15769&sLeft=2<ype=my&rtype=my .
Keyphrases
- patients undergoing
- minimally invasive
- coronary artery bypass
- mental health
- healthcare
- study protocol
- phase iii
- cell therapy
- single cell
- clinical trial
- genome wide
- bone marrow
- rna seq
- high dose
- phase ii
- surgical site infection
- health information
- randomized controlled trial
- platelet rich plasma
- open label
- low dose
- gene expression
- iron deficiency
- mesenchymal stem cells
- acute coronary syndrome
- social media
- placebo controlled